Special Issue: Partnership for Patients

An Overview of Measurement Activities in the Partnership for Patients

Hackbarth, Andrew D. MPhil*; Munier, William B. MD, MBA†; Eldridge, Noel MS†; Jordan, Jack MS*; Richards, Chesley MD, MPH‡; Brennan, Niall J. PhD*; Wagner, Dennis MPA*; McGann, Paul MD*

Author Information

From the *Centers for Medicare and Medicaid Services, Baltimore; †Agency for Healthcare Research and Quality, Rockville, Maryland; and ‡Centers for Disease Control and Prevention, Atlanta, Georgia.

Correspondence: Andrew D. Hackbarth, MPhil, Centers for Medicare and Medicaid Services, Baltimore, MD, 200 Independence Ave., SW, Washington, D.C. 20201 (e-mail: [email protected]).

Sources of support that require acknowledgement: None.

The authors are writing in their official capacities as Department of Health and Human Services staff. The date for reaching the PfP goals was extended from 2013 to 2014 after acceptance of this paper. See the HHS 2013 Annual Report to Congress - National Strategy for Quality Improvement in Health Care (page 11), available at: http://www.ahrq.gov/workingforquality/nqs/nqs2013annlrpt.pdf.

The authors disclose no conflict of interest.

Journal of Patient Safety 10(3):p 125-132, September 2014. | DOI: 10.1097/PTS.0000000000000071

Abstract

The Partnership for Patients, launched in April 2011, is a national quality improvement initiative from the Department of Health and Human Services that has set ambitious goals for U.S. providers to improve patient safety and care transitions. This paper outlines the initiative’s measurement strategy, describing four measurement-related objectives: (1) to track national progress toward the program goals that U.S. hospitals reduce preventable adverse events by 40% and readmissions by 20%; (2) to support local quality improvement measurement in participating hospitals by providing the appropriate tools, training, and programmatic structure; (3) to obtain feedback on hospital and contractor progress, in close to real time, so the project can be effectively managed; and (4) to evaluate the program’s impact on adverse event and readmission rates.

© 2014 by Lippincott Williams & Wilkins

Full Text Access for Subscribers:

Not a Subscriber?

Buy
Request Permissions

You can read the full text of this article if you:

Access through Ovid